Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment

BACKGROUND: Anthracycline chemotherapy and thoracic radiation therapy (RT) are known causes of cardiomyopathy among cancer survivors, however, management guidelines for this population are lacking. In this study we describe our single institution management approach for cancer survivors with low lef...

Descripción completa

Detalles Bibliográficos
Autores principales: Delavar, Arash, Boutros, Catherine, Barnea, Dana, MD, Wendy L. Schaffer, Tonorezos, Emily S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097116/
https://www.ncbi.nlm.nih.gov/pubmed/35551674
http://dx.doi.org/10.1186/s40959-022-00138-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097116/
https://www.ncbi.nlm.nih.gov/pubmed/35551674
http://dx.doi.org/10.1186/s40959-022-00138-x

Ejemplares similares